Cooley Advises Adamas Pharmaceuticals on Initial Public Offering

San Francisco – April 30, 2014 – Cooley LLP announced today that it advised Adamas Pharmaceuticals, Inc. on its initial public offering. Adamas Pharmaceuticals, a specialty pharmaceutical company driven to improve the lives of those affected by chronic disorders of the central nervous system, now trades on the NASDAQ Global Stock Market under the symbol "ADMS."

The Cooley corporate and securities team advising Adamas was led by partners Robert Jones and Kenn Guernsey and included partner Danielle Naftulin and associates Seth Gottlieb, Matt Roberts, David Ambler and Katie Stevens. Critical support for the offering was provided by partner Renee Deming and special counsel Jeannie Leahy (compensation & benefits); partner Mark Windfeld-Hansen (tax); partner Natasha Leskovsek (regulatory); partner Michael Tuscan and associate Fraser Brown (intellectual property); and partner Lila Hope and associates Bin Wang and Jennifer Raab (technology transactions).

Thus far in 2014, Cooley has advised on 43 completed public offerings, including 22 completed IPOs.

About Cooley LLP

Cooley's attorneys solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and bet-the-company litigation, often where innovation meets the law.

Cooley has more than 750 lawyers across 11 offices in the United States and China.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.